Neil Gallagher - President, Head of R&D at Syndax Pharmaceuticals Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
President, Head of R&D
Issuer Symbol
SNDX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Neil Gallagher since 16 Feb 2025

Holdings reported by Neil Gallagher for Syndax Pharmaceuticals Inc

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Options (Right to buy) 110,500 $1,618,825 $14.65 05 Feb 2025 Direct Common Stock
Common Stock 85,095 $1,319,313 $15.50 10 Feb 2025 Direct

Transactions reported by Neil Gallagher for Syndax Pharmaceuticals Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.